HomeMRVL • CVE
add
Marvel Biosciences Corp
Previous close
$0.10
Day range
$0.10 - $0.11
Year range
$0.060 - $0.18
Market cap
4.48M CAD
Avg Volume
41.32K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jan 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 528.26K | 131.93% |
Net income | -485.61K | -108.58% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jan 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 59.53K | -89.69% |
Total assets | 219.08K | -69.19% |
Total liabilities | 3.77M | 18.96% |
Total equity | -3.55M | — |
Shares outstanding | 44.80M | — |
Price to book | -1.25 | — |
Return on assets | -589.94% | — |
Return on capital | 82.30% | — |
Cash Flow
Net change in cash
| (CAD) | Jan 2025info | Y/Y change |
|---|---|---|
Net income | -485.61K | -108.58% |
Cash from operations | -26.38K | 88.98% |
Cash from investing | — | — |
Cash from financing | 2.62K | -99.48% |
Net change in cash | -23.76K | -109.11% |
Free cash flow | 106.69K | 165.50% |
About
Founded
2021
Headquarters
Website
